ERAS Erasca, Inc. - Common Stock
$18,05
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$1–$24
73% of range
Analystenbewertung
BUY
17 analysts
Kursziel
$23
+29% upside
P/E (TTM)
-41.0
ROE
-35.7%
Nettogewinnmarge
—
ERAS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$18.05
Marktkapitalisierung
$5.13B
P/E (TTM)
-41.0
EPS (TTM)
$-0.44
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-35.7%
Verschuldungsgrad
—
52W-Spanne
$1 – $24
ERAS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-0.44
2021-12-31
→
2025-12-31
Freier Cashflow
$-96M
2021-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ERAS
Peer-Median
P/E (TTM)
-41.0
16.0
P/B (K/B)
15.8
8.5
Price / FCF (Kurs / FCF)
-53.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ERAS
Peer-Median
ROA
-27.7%
-45.0%
ROE
-35.7%
-86.5%
ROIC
-43.3%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ERAS
Peer-Median
Current Ratio (Liquiditätsgrad)
10.0
7.0
Quick Ratio
9.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ERAS
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ERAS
Peer-Median
ERAS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
17 Analysten
- Starker Kauf 5 29,4%
- Kauf 9 52,9%
- Halten 3 17,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-16
Median
$22.50
Mittelwert
$23.30
← Unter allen Zielen
$18.05
Tief
$20.00
Hoch
$30.00
Median-Ziel
$22.50
+24,7%
Mittelwert-Ziel
$23.30
+29,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.07%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.60 | $-0.21 | -0.39% |
| 31. Dezember 2025 | $-0.10 | $-0.11 | 0.01% |
| 30. September 2025 | $-0.11 | $-0.11 | -0.00% |
| 30. Juni 2025 | $-0.12 | $-0.11 | -0.01% |
| 31. März 2025 | $-0.11 | $-0.13 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ERAS | $1.06B | -8.5 | — | — | -35.7% | — |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| SG&A Expense | $39M | $42M | $38M | $33M | $23M | $8M | |
| Operating Expenses | $141M | $180M | $142M | $247M | $125M | $109M | |
| Operating Income | $-141M | $-180M | $-142M | $-247M | $-125M | $-109M | |
| Other Non-op | $16M | $18M | $16M | $5M | $314.0K | $-102.0K | |
| Pretax Income | $-125M | $-162M | · | · | · | · | |
| Income Tax | $0 | $0 | · | · | · | · | |
| Net Income | $-125M | $-162M | $-125M | $-243M | $-123M | $-102M | |
| EPS (Basic) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| EPS (Diluted) | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 | · | |
| Shares (Basic) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| Shares (Diluted) | 283,533,696 | 233,817,916 | 150,184,994 | 122,024,848 | 66,290,592 | · | |
| EBITDA | $-138M | $-176M | $-138M | $-245M | $-124M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $68M | $93M | $284M | $360M | $65M | |
| Short-term Investments | $202M | $231M | $219M | $151M | $54M | $53M | |
| Prepaid Expense | $10M | $10M | $8M | $9M | $6M | $1M | |
| Current Assets | $286M | $309M | $321M | $444M | $420M | $120M | |
| PP&E (Net) | $13M | $16M | $22M | $25M | $16M | $2M | |
| PP&E (Gross) | $26M | $26M | $30M | $28M | $18M | $3M | |
| Accum. Depreciation | $13M | $10M | $7M | $4M | $2M | $902.0K | |
| Other Non-current Assets | $1M | $3M | $4M | $5M | $3M | $451.0K | |
| Total Assets | $396M | $503M | $395M | $515M | $501M | $125M | |
| Accounts Payable | $981.0K | $468.0K | $2M | $23M | $5M | $878.0K | |
| Current Liabilities | $29M | $31M | $26M | $49M | $26M | $14M | |
| Capital Leases | $42M | $47M | $52M | $54M | $19M | $2M | |
| Other Non-current Liabilities | $399.0K | $362.0K | $566.0K | $573.0K | $158.0K | · | |
| Total Liabilities | $71M | $79M | $79M | $103M | $45M | $17M | |
| Common Stock | $28.0K | $28.0K | $15.0K | $15.0K | $12.0K | $3.0K | |
| Retained Earnings | $-892M | $-768M | $-606M | $-481M | $-238M | $-115M | |
| AOCI | $628.0K | $405.0K | $77.0K | $-1M | $-162.0K | $2.0K | |
| Stockholders' Equity | $325M | $423M | $317M | $412M | $457M | $-114M | |
| Liabilities + Equity | $396M | $503M | $395M | $515M | $501M | $125M | |
| Shares Outstanding | 284,159,076 | 283,218,344 | 151,090,227 | 149,333,258 | 119,102,505 | 21,923,173 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $3M | $4M | $4M | $3M | $829.0K | $540.0K | |
| Stock-based Comp | $25M | $27M | $26M | $20M | $8M | $797.0K | |
| Other Non-cash | $1M | $21M | $-6M | $117M | $34M | · | |
| Operating Cash Flow | $-95M | $-109M | $-101M | $-103M | $-80M | $-33M | |
| CapEx | $128.0K | $60.0K | $2M | $15M | $11M | $947.0K | |
| Investing Cash Flow | $100M | $-157M | $-91M | $-71M | $-65M | $-71M | |
| Stock Issued | · | · | · | $95M | · | · | |
| Net Stock Activity | · | · | · | $95M | · | · | |
| Financing Cash Flow | $1M | $241M | $1M | $98M | $439M | $140M | |
| Net Change in Cash | $6M | $-25M | $-191M | $-76M | $295M | $36M | |
| Free Cash Flow | $-96M | $-109M | $-103M | $-118M | $-91M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -27.7% | -36.0% | -27.5% | -47.8% | -39.2% | · | |
| ROE | -35.7% | -37.0% | -38.1% | -62.5% | -26.1% | · | |
| ROIC | -43.3% | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 | · | |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-125M | $-162M | $-125M | $-243M | $-123M | · | |
| Market Cap | $1.06B | $711M | $322M | $644M | $1.86B | · | |
| P/E | -8.5 | -3.6 | -2.6 | -2.2 | -8.4 | · | |
| P/B | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Tangible Book | 3.3 | 1.7 | 1.0 | 1.6 | 4.1 | · | |
| P / Cash Flow | -11.1 | -6.5 | -3.2 | -6.2 | -23.3 | · | |
| P / FCF | -11.1 | -6.5 | -3.1 | -5.5 | -20.4 | · | |
| Earnings Yield | -11.8% | -27.5% | -39.0% | -46.2% | -11.9% | · |
Gewinn- und Verlustrechnung 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $12M | $11M | $9M | $10M | $9M | $10M | $10M | $10M | $12M | $10M | $9M | $9M | $10M | $9M | $9M | $9M | |
| Operating Expenses | $48M | $188M | $33M | $35M | $38M | $36M | $36M | $37M | $68M | $39M | $34M | $35M | $36M | $37M | $138M | $37M | |
| Operating Income | $-48M | $-188M | $-33M | $-35M | $-38M | $-36M | $-36M | $-37M | $-68M | $-39M | $-34M | $-35M | $-36M | $-37M | $-138M | $-37M | |
| Other Non-op | $4M | $22.0K | $7M | $-37.0K | $4M | $-76.0K | $9M | $173.0K | $5M | $4M | $9M | $-49.0K | $4M | $4M | $3M | $1M | |
| Net Income | $-44M | $-183M | $-29M | $-31M | $-34M | $-31M | $-32M | $-31M | $-63M | $-35M | $-30M | $-30M | $-32M | $-33M | $-135M | $-35M | |
| EPS (Basic) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| EPS (Diluted) | $-0.14 | $-0.60 | $-0.10 | $-0.11 | $-0.12 | $-0.11 | $-0.06 | $-0.11 | $-0.29 | $-0.23 | $-0.20 | $-0.20 | $-0.21 | $-0.22 | $-1.09 | $-0.29 | |
| Shares (Basic) | 311,336,806 | 304,317,460 | -566,763,893 | 283,681,570 | 283,355,730 | 283,260,289 | -417,535,356 | 282,384,964 | 217,806,567 | 151,161,741 | -299,806,452 | 150,450,201 | 150,037,029 | 149,504,216 | -238,458,880 | 120,798,322 | |
| Shares (Diluted) | 311,336,806 | 304,317,460 | -566,763,893 | 283,681,570 | 283,355,730 | 283,260,289 | -417,535,356 | 282,384,964 | 217,806,567 | 151,161,741 | -299,806,452 | 150,450,201 | 150,037,029 | 149,504,216 | -238,458,880 | 120,798,322 | |
| EBITDA | $-47M | $-187M | · | $-34M | $-37M | $-35M | · | $-36M | $-67M | $-38M | · | $-34M | $-35M | $-36M | · | $-36M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $47M | $74M | $70M | $66M | $70M | $68M | $69M | $173M | $77M | $93M | $113M | $139M | $273M | $284M | $219M | |
| Short-term Investments | $226M | $197M | $202M | $218M | $235M | $234M | $231M | $250M | $236M | $221M | $219M | $184M | $178M | $117M | $151M | $137M | |
| Prepaid Expense | $10M | $10M | $10M | $12M | $10M | $10M | $10M | $11M | $10M | $9M | $8M | $9M | $7M | $8M | $9M | $10M | |
| Current Assets | $278M | $254M | $286M | $300M | $311M | $315M | $309M | $330M | $418M | $307M | $321M | $306M | $324M | $398M | $444M | $366M | |
| PP&E (Net) | $12M | $13M | $13M | $14M | $15M | $16M | $16M | $17M | $18M | $21M | $22M | $23M | $24M | $25M | $25M | $25M | |
| PP&E (Gross) | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $26M | $30M | $30M | $30M | $29M | $29M | $28M | $27M | |
| Accum. Depreciation | $14M | $13M | $13M | $12M | $11M | $11M | $10M | $9M | $8M | $8M | $7M | $6M | $5M | $4M | $4M | $3M | |
| Other Non-current Assets | $1M | $1M | $1M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | |
| Total Assets | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Accounts Payable | $2M | $2M | $981.0K | $3M | $2M | $2M | $468.0K | $2M | $2M | $3M | $2M | $4M | $3M | $3M | $23M | $4M | |
| Current Liabilities | $34M | $27M | $29M | $29M | $28M | $25M | $31M | $30M | $25M | $30M | $26M | $27M | $23M | $26M | $49M | $28M | |
| Capital Leases | $39M | $41M | $42M | $43M | $45M | $46M | $47M | $48M | $50M | $51M | $52M | $53M | $54M | $55M | $54M | $53M | |
| Other Non-current Liabilities | $341.0K | $340.0K | $399.0K | $395.0K | $263.0K | $251.0K | $362.0K | $340.0K | $82.0K | $559.0K | $566.0K | $761.0K | $697.0K | $630.0K | $573.0K | · | |
| Total Liabilities | $73M | $68M | $71M | $73M | $73M | $72M | $79M | $79M | $75M | $82M | $79M | $80M | $78M | $81M | $103M | $81M | |
| Common Stock | $31.0K | $31.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $28.0K | $27.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $15.0K | $12.0K | |
| Retained Earnings | $-1.12B | $-1.08B | $-892M | $-863M | $-833M | $-799M | $-768M | $-735M | $-704M | $-641M | $-606M | $-576M | $-546M | $-514M | $-481M | $-346M | |
| AOCI | $-1M | $-699.0K | $628.0K | $649.0K | $415.0K | $628.0K | $405.0K | $2M | $-196.0K | $-210.0K | $77.0K | $-575.0K | $-793.0K | $-514.0K | $-1M | $-1M | |
| Stockholders' Equity | $362M | $394M | $325M | $348M | $372M | $400M | $423M | $450M | $451M | $288M | $317M | $339M | $363M | $386M | $412M | $365M | |
| Liabilities + Equity | $435M | $461M | $396M | $420M | $445M | $471M | $503M | $529M | $526M | $370M | $395M | $419M | $441M | $468M | $515M | $446M | |
| Shares Outstanding | 312,556,206 | 310,806,888 | 284,159,076 | 283,711,805 | 283,650,139 | 283,265,716 | 283,218,344 | 282,690,975 | 273,039,997 | 151,249,219 | 151,090,227 | 150,537,752 | 150,383,261 | 149,699,528 | 149,333,258 | 121,024,938 |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $716.0K | $723.0K | $743.0K | $755.0K | $787.0K | $822.0K | $865.0K | $842.0K | $1M | $998.0K | $942.0K | $941.0K | $955.0K | $894.0K | $933.0K | $771.0K | |
| Stock-based Comp | $10M | $8M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $6M | $6M | $7M | $7M | $5M | $5M | |
| Other Non-cash | · | $147M | · | · | · | $-8M | · | · | · | $-6M | · | · | · | $-898.0K | · | · | |
| Operating Cash Flow | $-27M | $-27M | $-22M | $-22M | $-21M | $-32M | $-25M | $-22M | $-29M | $-33M | $-25M | $-24M | $-26M | $-26M | $-26M | $-24M | |
| CapEx | $8.0K | $36.0K | $9.0K | $6.0K | $30.0K | $83.0K | $0 | $5.0K | $13.0K | $42.0K | $82.0K | $240.0K | $247.0K | $1M | $864.0K | $2M | |
| Investing Cash Flow | $19M | $-244M | $25M | $26M | $16M | $34M | $23M | $-103M | $-87M | $10M | $5M | $-2M | $-109M | $15M | $-5M | $-55M | |
| Stock Issued | $0 | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $259M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $245M | $575.0K | $41.0K | $447.0K | $33.0K | $801.0K | $21M | $212M | $7M | $456.0K | $7.0K | $649.0K | $183.0K | $96M | $427.0K | |
| Net Change in Cash | $-5M | $-27M | $4M | $4M | $-4M | $3M | $-1M | $-104M | $96M | $-16M | $-20M | $-26M | $-134M | $-11M | $65M | $-79M | |
| Free Cash Flow | · | $-27M | · | · | · | $-32M | · | · | · | $-33M | · | · | · | $-28M | · | · |
Rentabilität 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.0% | -39.3% | · | -6.5% | -7.0% | -7.4% | · | -6.6% | -13.1% | -8.4% | · | -7.0% | -7.2% | -7.0% | · | -7.3% | |
| ROE | -12.0% | -46.3% | · | -7.7% | -8.2% | -9.0% | · | -7.9% | -15.5% | -10.4% | · | -8.6% | -8.4% | -8.2% | · | -8.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.3 | 9.5 | · | 10.4 | 11.0 | 12.4 | · | 11.0 | 16.8 | 10.1 | · | 11.4 | 13.9 | 15.6 | · | 13.2 | |
| Quick Ratio | 8.0 | 9.1 | · | 10.0 | 10.7 | 12.0 | · | 10.6 | 16.4 | 9.8 | · | 11.1 | 13.6 | 15.3 | · | 12.9 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-292M | $-279M | · | $-127M | $-159M | $-160M | · | $-160M | $-160M | $-130M | · | $-131M | $-136M | $-141M | · | $-154M | |
| Market Cap | $5.73B | $5.03B | · | $618M | $360M | $388M | · | $772M | $644M | $312M | · | $297M | $415M | $451M | · | $944M | |
| P/E | -18.9 | -17.2 | · | -4.8 | -2.0 | -1.9 | · | -3.3 | -2.5 | -2.4 | · | -2.1 | -2.7 | -2.7 | · | -5.7 | |
| P/B | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Tangible Book | 15.8 | 12.8 | · | 1.8 | 1.0 | 1.0 | · | 1.7 | 1.4 | 1.1 | · | 0.9 | 1.1 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | -183.6 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -17.1 | · | · | |
| P / FCF | · | -183.4 | · | · | · | -12.3 | · | · | · | -9.4 | · | · | · | -16.3 | · | · | |
| Earnings Yield | -5.3% | -5.8% | · | -20.6% | -49.6% | -54.0% | · | -30.4% | -39.4% | -41.8% | · | -46.7% | -37.0% | -37.2% | · | -17.4% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Nettoergebnis | $-125M | $-162M | $-125M | $-243M | $-123M |
| Verwässerte EPS | $-0.44 | $-0.69 | $-0.83 | $-1.99 | $-1.85 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 10.0 | 9.8 | 12.3 | 9.1 | 15.9 |
| Quick Ratio | 9.7 | 9.5 | 11.9 | 8.9 | 15.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-96M | $-109M | $-103M | $-118M | $-91M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20
- Warum dieser Fonds ein $189 Millionen-Bet auf Erasca gewagt hat, während die Aktien um 800% steigen
- Acuta Capital wettet auf Erasca (ERAS) und gezielte Krebsbehandlungen mit einem Kauf von 354.575 Aktien
- JPMorgan empfiehlt den Kauf von Erasca (ERAS) Aktien auf aktuellem Niveau
- Erasca (ERAS) klettert YTD um 390 % dank Potenzial für Krebsbehandlung als „Best-in-Class“
- Was treibt Erascas (ERAS) fast 355% YTD-Rendite an
- Erasca (ERAS) erhöht sich um 13 %; steigt YTD um 310 %.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 277 Einreicher · $4.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 74 (-16 vs. Vorquartal) | 25 (+4 vs. Vorquartal) | 100 (+23 vs. Vorquartal) | 71 (+32 vs. Vorquartal) | +30.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $457.545.444 | 24.975.188 | 11,02% | Aktien |
| RTW INVESTMENTS, LP | $328.784.533 | 17.946.754 | 7,92% | Aktien |
| Venrock Adviser, LLC | $327.777.996 | 17.891.812 | 7,89% | Aktien |
| STATE STREET CORP | $223.221.048 | 12.184.555 | 5,37% | Aktien |
| Logos Global Management LP | $222.588.000 | 12.150.000 | 5,36% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $208.888.286 | 11.402.199 | 5,03% | Aktien |
| Siren, L.L.C. | $208.807.348 | 11.397.781 | 5,03% | Aktien |
| Paradigm Biocapital Advisors LP | $174.956.000 | 9.550.000 | 4,21% | Aktien |
| ARCH Venture Management, LLC | $129.917.324 | 7.091.557 | 3,13% | Aktien |
| Cormorant Asset Management, LP | $109.920.000 | 6.000.000 | 2,65% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $103.973.538 | 5.674.177 | 2,50% | Aktien |
| Affinity Asset Advisors, LLC | $96.180.000 | 5.250.000 | 2,32% | Aktien |
| Vivo Capital, LLC | $75.614.188 | 4.127.412 | 1,82% | Aktien |
| Caption Management, LLC | $68.535.120 | 3.741.000 | 1,65% | Kaufoption |
| ALLIANCEBERNSTEIN L.P. | $66.639.175 | 4.118.614 | 1,60% | Aktien |
| GOLDMAN SACHS GROUP INC | $61.635.625 | 3.364.390 | 1,48% | Aktien |
| FMR LLC | $52.713.528 | 2.877.376 | 1,27% | Aktien |
| a16z Capital Management, L.L.C. | $52.441.000 | 2.862.500 | 1,26% | Aktien |
| Woodline Partners LP | $51.879.803 | 2.831.867 | 1,25% | Aktien |
| JENNISON ASSOCIATES LLC | $51.083.708 | 2.788.412 | 1,23% | Aktien |
| Soleus Capital Management, L.P. | $49.464.000 | 2.700.000 | 1,19% | Aktien |
| BANK OF AMERICA CORP /DE/ | $47.608.477 | 2.598.716 | 1,15% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $43.782.308 | 2.389.864 | 1,05% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $37.410.063 | 2.042.034 | 0,90% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $35.628.553 | 1.944.790 | 0,86% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $35.475.984 | 1.936.462 | 0,85% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $31.107.195 | 1.697.991 | 0,75% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $29.616.277 | 1.616.609 | 0,71% | Aktien |
| UBS Group AG | $29.005.287 | 1.583.258 | 0,70% | Aktien |
| STEMPOINT CAPITAL LP | $28.687.526 | 1.565.913 | 0,69% | Aktien |
| Rock Springs Capital Management LP | $25.687.388 | 1.402.150 | 0,62% | Aktien |
| Evergreen Quality Fund GP, Ltd. | $25.195.496 | 1.375.300 | 0,61% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $25.078.578 | 1.368.918 | 0,60% | Aktien |
| FRED ALGER MANAGEMENT, LLC | $23.970.896 | 1.308.455 | 0,58% | Aktien |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23.138.636 | 1.263.026 | 0,56% | Aktien |
| Point72 Asset Management, L.P. | $22.848.759 | 1.247.203 | 0,55% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $22.780.920 | 1.243.500 | 0,55% | Kaufoption |
| First Turn Management, LLC | $22.381.929 | 1.221.721 | 0,54% | Aktien |
| Caption Management, LLC | $19.075.242 | 1.041.225 | 0,46% | Aktien |
| Integral Health Asset Management, LLC | $18.320.000 | 1.000.000 | 0,44% | Aktien |
| D. E. Shaw & Co., Inc. | $17.152.833 | 936.290 | 0,41% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $16.667.792 | 909.814 | 0,40% | Aktien |
| SAMLYN CAPITAL, LLC | $15.782.405 | 861.485 | 0,38% | Aktien |
| Assenagon Asset Management S.A. | $14.891.888 | 812.876 | 0,36% | Aktien |
| MARSHALL WACE, LLP | $13.534.999 | 738.810 | 0,33% | Aktien |
| Caption Management, LLC | $13.245.360 | 723.000 | 0,32% | Verkaufsoption |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $13.142.353 | 718.554 | 0,32% | Aktien |
| Capital World Investors | $12.908.309 | 704.602 | 0,31% | Aktien |
| CITIGROUP INC | $12.860.310 | 701.982 | 0,31% | Aktien |
| JANE STREET GROUP, LLC | $12.752.552 | 696.100 | 0,31% | Kaufoption |
| TD Asset Management Inc | $12.112.305 | 661.152 | 0,29% | Aktien |
| Balyasny Asset Management L.P. | $12.057.766 | 658.175 | 0,29% | Aktien |
| Balyasny Asset Management L.P. | $10.992.000 | 600.000 | 0,26% | Kaufoption |
| AMERIPRISE FINANCIAL INC | $10.038.170 | 547.935 | 0,24% | Aktien |
| JANE STREET GROUP, LLC | $9.855.116 | 537.943 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9.649.144 | 526.700 | 0,23% | Verkaufsoption |
| ORBIMED ADVISORS LLC | $9.084.888 | 495.900 | 0,22% | Aktien |
| Polymer Capital Management (HK) LTD | $8.757.326 | 478.020 | 0,21% | Aktien |
| BlackRock, Inc. | $8.538.732 | 466.088 | 0,21% | Aktien |
| KVP Capital Advisors, LP | $8.335.600 | 455.000 | 0,20% | Aktien |
| Spruce Street Capital LP | $7.740.988 | 422.543 | 0,19% | Aktien |
| Pictet Asset Management Holding SA | $7.194.043 | 393.288 | 0,17% | Aktien |
| Cinctive Capital Management LP | $7.174.881 | 391.642 | 0,17% | Aktien |
| CITADEL ADVISORS LLC | $6.961.600 | 380.000 | 0,17% | Kaufoption |
| Rhenman & Partners Asset Management AB | $6.393.680 | 349.000 | 0,15% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.369.058 | 347.656 | 0,15% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $6.225.136 | 339.800 | 0,15% | Aktien |
| EcoR1 Capital, LLC | $6.045.600 | 330.000 | 0,15% | Aktien |
| Swiss National Bank | $5.714.008 | 311.900 | 0,14% | Aktien |
| Longaeva Partners L.P. | $5.245.419 | 286.322 | 0,13% | Aktien |
| SIMPLEX TRADING, LLC | $5.074.420 | 276.988 | 0,12% | Aktien |
| VANGUARD GROUP INC | $4.976.928 | 1.337.884 | 0,12% | Aktien |
| E Fund Management Co., Ltd. | $4.861.780 | 265.381 | 0,12% | Aktien |
| ACUTA CAPITAL PARTNERS, LLC | $4.858.446 | 265.199 | 0,12% | Aktien |
| Parkman Healthcare Partners LLC | $4.739.091 | 258.684 | 0,11% | Aktien |
| RHUMBLINE ADVISERS | $4.696.633 | 256.367 | 0,11% | Aktien |
| ROYAL BANK OF CANADA | $4.580.000 | 250.000 | 0,11% | Aktien |
| CITADEL ADVISORS LLC | $4.354.664 | 237.700 | 0,10% | Verkaufsoption |
| ArrowMark Colorado Holdings LLC | $3.864.183 | 210.927 | 0,09% | Aktien |
| Seven Fleet Capital Management LP | $3.853.539 | 210.346 | 0,09% | Aktien |
| Rafferty Asset Management, LLC | $3.782.402 | 206.463 | 0,09% | Aktien |
| Man Group plc | $3.710.771 | 202.553 | 0,09% | Aktien |
| WELLS FARGO & COMPANY/MN | $3.345.232 | 182.600 | 0,08% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3.307.985 | 204.449 | 0,08% | Aktien |
| Moody Aldrich Partners LLC | $3.259.842 | 177.939 | 0,08% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.151.150 | 172.006 | 0,08% | Aktien |
| JANE STREET GROUP, LLC | $2.964.176 | 161.800 | 0,07% | Verkaufsoption |
| HighVista Strategies LLC | $2.937.208 | 160.328 | 0,07% | Aktien |
| Atom Investors LP | $2.927.738 | 159.811 | 0,07% | Aktien |
| Quantinno Capital Management LP | $2.735.121 | 149.297 | 0,07% | Aktien |
| NOMURA HOLDINGS INC | $2.610.600 | 142.500 | 0,06% | Aktien |
| Squarepoint Ops LLC | $2.477.469 | 135.233 | 0,06% | Aktien |
| PFM Health Sciences, LP | $2.456.492 | 134.088 | 0,06% | Aktien |
| Holocene Advisors, LP | $2.318.396 | 126.550 | 0,06% | Aktien |
| WELLS FARGO & COMPANY/MN | $2.315.648 | 126.400 | 0,06% | Kaufoption |
| EDBI Pte Ltd | $2.231.109 | 888.888 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $2.161.815 | 118.003 | 0,05% | Aktien |
| Corient Private Wealth LP | $2.150.348 | 117.377 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $2.143.293 | 116.992 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $2.135.654 | 116.575 | 0,05% | Aktien |
Unternehmensinsider 13 Insider · 5 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jonathan E Lim | Chairman & CEO | 29. Januar 2026 A | 12.899.360 | 0 | 0 | $0 |
| David M. Chacko | CFO and CBO | 29. Januar 2026 A | 279.980 | 0 | 0 | $0 |
| Ebun Garner | Chief Legal Officer | 1. April 2026 M | 25.076 | 0 | 2 | $-1.982.800 |
| Shannon Morris | Chief Medical Officer | 4. März 2025 M | 0 | 0 | 1 | $-300.800 |
| Lin Wei | Chief Medical Officer | 1. Februar 2023 A | 315.812 | 0 | 0 | $0 |
| James Arthur Bristol | Direktor | 26. Juni 2026 A | 20.000 | 0 | 0 | $0 |
| Valerie Denise Harding Start | Direktor | 26. Juni 2026 A | 20.000 | 0 | 0 | $0 |
| Pratik S Multani | Direktor | 26. Juni 2026 A | 6.200 | 0 | 0 | $0 |
| Julie Hambleton | Direktor | 26. Juni 2026 A | 6.000 | 0 | 0 | $0 |
| Alexander W. Casdin | Direktor | 26. Juni 2026 A | 573.974 | 0 | 0 | $0 |
| Jean I Liu | Direktor | 26. Juni 2026 A | — | 0 | 0 | $0 |
| Michael David Varney | Direktor | 29. Januar 2026 A | — | 0 | 0 | $0 |
| Charles S. Fuchs | — | 10. August 2026 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund II, LP, Cormorant Private Healthcare GP II, LLC, Cormorant Asset Management, LP, Bihua Chen ×4 Einreichungen | 30. Januar 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 47 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 2,87% | 384.783 SH | 8. August 2026 | Täglich |
| BBC · ETFis Series Trust I | 2,19% | 76.668 NS | 30. April 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,64% | 400.259 SH | 8. August 2026 | Täglich |
| CANC · Tema ETF Trust | 1,08% | 147.828 NS | 31. Mai 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,56% | 271.194 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,39% | 16.922 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,29% | 1.530.081 SH | 8. August 2026 | Täglich |
| FSCC · Federated Hermes ETF Trust | 0,29% | 62.243 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,25% | 1.997.856 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,22% | 244.429 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,22% | 214.594 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,20% | 11.444 NS | 31. Mai 2026 | N-PORT |
| ESSC · Strategy Shares | 0,18% | 4.365 NS | 30. April 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,14% | 21.222 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,13% | 5.592.531 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,13% | 48.366 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 1.151.944 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,10% | 237.029 SH | 8. August 2026 | Täglich |
| SMMV · iShares Trust | 0,08% | 13.271 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,08% | 129.228 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 123.380 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 1.147.686 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,06% | 82.173 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 8.927 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 9.608 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,05% | 2.745.733 SH | 8. August 2026 | Täglich |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 394 NS | 31. Mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,04% | 467.663 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 27.794 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,04% | 6.982 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 78.076 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,03% | 10.376 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,03% | 7.067 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 43.576 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 263.455 NS | 30. April 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 177 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 6.020 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 8.386.105 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.688 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 402.637 NS | 30. April 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 76.593 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 334.895 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 58.513 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 136.333 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 18.981 NS | 30. April 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 33.981 NS | 30. April 2026 | N-PORT |
| AVLC · AMERICAN CENTURY ETF TRUST | 0,00% | 196 NS | 31. Mai 2026 | N-PORT |